.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recently, the Government of Punjab has made rapid progress in implementing its flagship healthcare initiative, the Mukh Mantri Sehat Yojna.
Furthermore, Chief Minister Bhagwant Mann announced that over 3.79 lakh patients have already availed of cashless medical treatments.
This scheme provides free medical care up to Rs 10 lakh for every family in the state.
Consequently, the program is transforming universal healthcare access across Punjab.
To begin with, officials have issued 47.27 lakh health cards under this program.
These cards cover approximately 23.01 lakh families in Punjab.
Specifically, women represent 51.5 per cent of the cardholders, while men account for 48.5 per cent.
Additionally, rural residents hold 69 per cent of these cards, compared to 31 per cent in urban areas.
In order to simplify the process, the government is developing a WhatsApp-based download facility.
Similarly, a new mobile application is underway to assist with registrations.
Importantly, the state has empanelled 835 hospitals under the scheme to ensure broad medical access.
This network includes 223 government hospitals and 612 private clinics.
Therefore, patients can access high-quality treatment near their homes.
Moreover, the program has disbursed Rs 654 crore to settle medical claims so far.
For instance, the health department spent around Rs 86 lakh on treating critical respiratory illnesses.
Overall, the initiative seeks to cover all 65 lakh families in the state of Punjab.
Q1: What is the maximum coverage under the Mukh Mantri Sehat Yojna?
The scheme offers free and cashless medical treatment of up to Rs 10 lakh per family annually without any income restrictions.
Q2: How many hospitals are empanelled under this health scheme?
A total of 835 healthcare facilities are currently empanelled under the scheme. This network consists of 223 government hospitals and 612 private medical centers.
Q3: How is the government improving card accessibility for beneficiaries?
Specifically, the government is developing a WhatsApp-based facility, a web portal, and a mobile app to simplify card downloading.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Explore how Punjab's latest healthcare initiative provides free and cashless medical treatment to millions of families across the state....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
